Institutional shares held 54.1 Million
986K calls
90.1K puts
Total value of holdings $663M
$12.1M calls
$1.1M puts
Market Cap $301M
24,602,000 Shares Out.
Institutional ownership 219.89%
# of Institutions 146


Latest Institutional Activity in KALV

Top Purchases

Q2 2025
Ameriprise Financial Inc Shares Held: 945K ($11.6M)
Q2 2025
Woodline Partners LP Shares Held: 1.92M ($23.5M)
Q2 2025
State Street Corp Shares Held: 1.35M ($16.5M)
Q2 2025
Susquehanna International Group, LLP Shares Held: 294K ($3.6M)
Q2 2025
Panagora Asset Management Inc Shares Held: 293K ($3.58M)

Top Sells

Q2 2025
Great Point Partners LLC Shares Held: 323K ($3.96M)
Q2 2025
Dimensional Fund Advisors LP Shares Held: 173K ($2.12M)
Q2 2025
Schonfeld Strategic Advisors LLC Shares Held: 145K ($1.78M)
Q2 2025
Allostery Investments LP Shares Held: 40K ($490K)
Q2 2025
Schroder Investment Management Group Shares Held: 555K ($6.8M)

About KALV

KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral plasma kallikrein inhibitors. Its products include KVD001, a plasma kallikrein inhibitor that completed a Phase II clinical trial for the treatment of DME; sebetralstat, which is initiation of the Phase 3 KONFIDENT trial as a potential oral, on-demand therapy for HAE attacks; KVD824, an oral product candidate for the treatment of HAE; and Factor XIIa, an oral inhibitor program which is in preclinical stage targets an enzyme in HAE. The company is headquartered in Cambridge, Massachusetts.


Insider Transactions at KALV

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
797K Shares
From 6 Insiders
Exercise of conversion of derivative security 289K shares
Grant, award, or other acquisition 148K shares
Open market or private purchase 361K shares
Sell / Disposition
203K Shares
From 3 Insiders
Open market or private sale 203K shares

Track Institutional and Insider Activities on KALV

Follow KalVista Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KALV shares.

Notify only if

Insider Trading

Get notified when an Kal Vista Pharmaceuticals, Inc. insider buys or sells KALV shares.

Notify only if

News

Receive news related to KalVista Pharmaceuticals, Inc.

Track Activities on KALV